Risk of Subsequent Breast Cancer in Human EGFR 2-Positive DCISRisk of Subsequent Breast Cancer in Human EGFR 2-Positive DCIS
What's the prognostic role of HER2 overexpression in patients with ductal carcinoma in situ? Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Health | Hematology | HER2